<?xml version='1.0' encoding='utf-8'?>
<document id="26744836"><sentence text="The inhibitory effects of camptothecin (CPT) and its derivatives on the substrate uptakes mediated by human solute carrier transporters (SLCs)."><entity charOffset="26-38" id="DDI-PubMed.26744836.s1.e0" text="camptothecin" /><entity charOffset="40-43" id="DDI-PubMed.26744836.s1.e1" text="CPT" /><pair ddi="false" e1="DDI-PubMed.26744836.s1.e0" e2="DDI-PubMed.26744836.s1.e0" /><pair ddi="false" e1="DDI-PubMed.26744836.s1.e0" e2="DDI-PubMed.26744836.s1.e1" /></sentence><sentence text="1" /><sentence text=" Camptothecin (CPT) and its derivatives are potent candidate compounds in treating cancers"><entity charOffset="0-13" id="DDI-PubMed.26744836.s3.e0" text=" Camptothecin" /><entity charOffset="15-18" id="DDI-PubMed.26744836.s3.e1" text="CPT" /><pair ddi="false" e1="DDI-PubMed.26744836.s3.e0" e2="DDI-PubMed.26744836.s3.e0" /><pair ddi="false" e1="DDI-PubMed.26744836.s3.e0" e2="DDI-PubMed.26744836.s3.e1" /></sentence><sentence text=" However, their clinical applications are largely restricted by severe toxicities" /><sentence text=" 2" /><sentence text=" The solute carrier transporters (SLCs), particularly the organic anion transporting polypeptides and organic anion/cation transporters (OATs/OCTs) are widely expressed in human key organs and responsible for the cellular influx of many substances including endogenous substrates and many clinically important drugs" /><sentence text=" Drug-drug interactions through SLCs often result in unsatisfied therapeutic outcomes and/or unexpected toxicities" /><sentence text=" 3" /><sentence text=" This study investigated the inhibitory effects of CPT and its eight derivatives on the cellular uptake of specific substrates mediated by the essential SLCs in over-expressing Human embryonic kidney 293 cells"><entity charOffset="51-53" id="DDI-PubMed.26744836.s9.e0" text="CPT" /></sentence><sentence text=" 4" /><sentence text=" Our data revealed that CPT, 10-hydroxycamptothecin (HCPT), 10-methoxycamptothecin (MCPT) and 9-nitrocamptothecin (9NC) significantly inhibit the uptake activity of OAT3"><entity charOffset="29-51" id="DDI-PubMed.26744836.s11.e0" text="10-hydroxycamptothecin" /><entity charOffset="53-57" id="DDI-PubMed.26744836.s11.e1" text="HCPT" /><entity charOffset="60-82" id="DDI-PubMed.26744836.s11.e2" text="10-methoxycamptothecin" /><entity charOffset="84-88" id="DDI-PubMed.26744836.s11.e3" text="MCPT" /><entity charOffset="94-113" id="DDI-PubMed.26744836.s11.e4" text="9-nitrocamptothecin" /><entity charOffset="115-118" id="DDI-PubMed.26744836.s11.e5" text="9NC" /><entity charOffset="24-26" id="DDI-PubMed.26744836.s11.e6" text="CPT" /><entity charOffset="54-56" id="DDI-PubMed.26744836.s11.e7" text="CPT" /><entity charOffset="85-87" id="DDI-PubMed.26744836.s11.e8" text="CPT" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e6" e2="DDI-PubMed.26744836.s11.e6" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e6" e2="DDI-PubMed.26744836.s11.e0" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e6" e2="DDI-PubMed.26744836.s11.e1" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e6" e2="DDI-PubMed.26744836.s11.e7" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e6" e2="DDI-PubMed.26744836.s11.e2" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e6" e2="DDI-PubMed.26744836.s11.e3" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e6" e2="DDI-PubMed.26744836.s11.e8" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e6" e2="DDI-PubMed.26744836.s11.e4" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e6" e2="DDI-PubMed.26744836.s11.e5" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e0" e2="DDI-PubMed.26744836.s11.e0" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e0" e2="DDI-PubMed.26744836.s11.e1" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e0" e2="DDI-PubMed.26744836.s11.e7" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e0" e2="DDI-PubMed.26744836.s11.e2" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e0" e2="DDI-PubMed.26744836.s11.e3" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e0" e2="DDI-PubMed.26744836.s11.e8" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e0" e2="DDI-PubMed.26744836.s11.e4" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e0" e2="DDI-PubMed.26744836.s11.e5" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e1" e2="DDI-PubMed.26744836.s11.e1" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e1" e2="DDI-PubMed.26744836.s11.e7" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e1" e2="DDI-PubMed.26744836.s11.e2" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e1" e2="DDI-PubMed.26744836.s11.e3" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e1" e2="DDI-PubMed.26744836.s11.e8" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e1" e2="DDI-PubMed.26744836.s11.e4" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e1" e2="DDI-PubMed.26744836.s11.e5" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e7" e2="DDI-PubMed.26744836.s11.e7" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e7" e2="DDI-PubMed.26744836.s11.e2" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e7" e2="DDI-PubMed.26744836.s11.e3" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e7" e2="DDI-PubMed.26744836.s11.e8" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e7" e2="DDI-PubMed.26744836.s11.e4" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e7" e2="DDI-PubMed.26744836.s11.e5" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e2" e2="DDI-PubMed.26744836.s11.e2" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e2" e2="DDI-PubMed.26744836.s11.e3" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e2" e2="DDI-PubMed.26744836.s11.e8" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e2" e2="DDI-PubMed.26744836.s11.e4" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e2" e2="DDI-PubMed.26744836.s11.e5" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e3" e2="DDI-PubMed.26744836.s11.e3" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e3" e2="DDI-PubMed.26744836.s11.e8" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e3" e2="DDI-PubMed.26744836.s11.e4" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e3" e2="DDI-PubMed.26744836.s11.e5" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e8" e2="DDI-PubMed.26744836.s11.e8" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e8" e2="DDI-PubMed.26744836.s11.e4" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e8" e2="DDI-PubMed.26744836.s11.e5" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e4" e2="DDI-PubMed.26744836.s11.e4" /><pair ddi="false" e1="DDI-PubMed.26744836.s11.e4" e2="DDI-PubMed.26744836.s11.e5" /></sentence><sentence text=" 9NC also inhibited the substrate transport mediated by OAT1"><entity charOffset="1-3" id="DDI-PubMed.26744836.s12.e0" text="9NC" /></sentence><sentence text=" The substrate uptakes of OAT1, OCTN1 and OCTN2 were significantly decreased in the presence of CZ112, while CPT-11 potently down-regulated the transport activity of OCT1 and OCT3"><entity charOffset="109-111" id="DDI-PubMed.26744836.s13.e0" text="CPT" /></sentence><sentence text=" 5" /><sentence text=" In summary, our study demonstrated that CPT and its eight derivatives selectively inhibit the substrate uptakes mediated by the essential SLCs"><entity charOffset="41-43" id="DDI-PubMed.26744836.s15.e0" text="CPT" /></sentence><sentence text=" This information contributes to understanding the localized toxicity of CPTs and provides novel molecular targets for the therapeutic optimization of CPTs in the future"><entity charOffset="73-75" id="DDI-PubMed.26744836.s16.e0" text="CPT" /><entity charOffset="151-153" id="DDI-PubMed.26744836.s16.e1" text="CPT" /><pair ddi="false" e1="DDI-PubMed.26744836.s16.e0" e2="DDI-PubMed.26744836.s16.e0" /><pair ddi="false" e1="DDI-PubMed.26744836.s16.e0" e2="DDI-PubMed.26744836.s16.e1" /></sentence><sentence text=" " /></document>